FDA inspection
Ascent Pharmaceuticals Inc: FDA inspection ending Feb 21, 2018
FDA inspection 1047500 · No Action Indicated (NAI) · Central Islip, NY
Key facts
| Inspection ID | 1047500 |
|---|---|
| Firm | Ascent Pharmaceuticals Inc |
| FEI number | 3009518416 |
| Address | 400 S Technology Dr |
| City | Central Islip |
| State | NY |
| ZIP | 11722 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Feb 21, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data